New Indication Approval: Boehringer Ingelheim’s asthma drug, Spiriva Respimat
Boehringer Ingelheim has announced that the US Food and Drug Administration (FDA) approved tiotropium Respimat (marketed as Spiriva Respimat) for the long-term,... Read More